Marco Bolis
Impact in
-
- Retinoids in leukemia and cellular processes
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- Retinoids in leukemia and cellular processes 13
- Protein Degradation and Inhibitors 3
- PI3K/AKT/mTOR signaling in cancer 3
- Oncology 8
- Co-authors
- Enrico Garattini (24 shared papers)Maddalena Fratelli (20 shared papers)Mineko Terao (20 shared papers)Gabriela Paroni (15 shared papers)Adriana Zanetti (13 shared papers)Maurizio Gianni’ (12 shared papers)Mami Kurosaki (16 shared papers)Maria Monica Barzago (9 shared papers)
- Journals
- Oncotarget (4 papers)Scientific Reports (3 papers)Cancers (3 papers)Cancer Research (3 papers)Nature Communications (2 papers)
- Partner nations
- ItalySwitzerlandGermany
In The Last Decade
Marco Bolis
43 papers receiving 929 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 143
- Molecular Biology 625
- Pharmacology 58
- Biochemistry 36
- Immunology 123
Countries citing papers authored by Marco Bolis
This map shows the geographic impact of Marco Bolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bolis more than expected).
Fields of papers citing papers by Marco Bolis
This network shows the impact of papers produced by Marco Bolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bolis. The network helps show where Marco Bolis may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Bolis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 104 | |
| 2 | 2016 | 84 | |
| 3 | 2022 | 71 | |
| 4 | 2018 | 62 | |
| 5 | 2015 | 59 | |
| 6 | 2012 | 50 | |
| 7 | 2015 | 47 | |
| 8 | 2019 | 39 | |
| 9 | 2015 | 32 | |
| 10 | 2020 | 31 | |
| 11 | 2016 | 29 | |
| 12 | 2016 | 26 | |
| 13 | 2014 | 24 | |
| 14 | 2018 | 21 | |
| 15 | 2020 | 20 | |
| 16 | Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy | 1993 | 19 |
| 17 | 2018 | 19 | |
| 18 | 2020 | 17 | |
| 19 | 2016 | 16 | |
| 20 | 2023 | 15 |
About Marco Bolis
Marco Bolis is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Physiology, having authored 48 papers that have together received 939 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (13 papers), Estrogen and related hormone effects (7 papers), Immune cells in cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Protein Degradation and Inhibitors (3 papers), Prostate Cancer Treatment and Research (3 papers), Antioxidant Activity and Oxidative Stress (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (143 citations), Molecular Biology (625 citations), Pharmacology (58 citations), Biochemistry (36 citations) and Immunology (123 citations). Marco Bolis has collaborated with scholars based in Italy, Switzerland and Germany. Frequent co-authors include Enrico Garattini, Maddalena Fratelli, Mineko Terao, Gabriela Paroni, Adriana Zanetti, Maurizio Gianni’, Mami Kurosaki, Maria Monica Barzago, Floriana Centritto and Silvio Ken Garattini. Their work appears in journals such as Oncotarget, Scientific Reports, Cancers, Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.